Condition: Severe Asthma · Sponsor: Generate Biomedicines
The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma that is uncontrolled by inhaled corticosteroids (ICS) and conventional asthma controllers. The study details include: Study treatment: randomized to receive either GB-0895 or placebo administered every 6 months over 52 weeks. Visit frequency: every 1-2 months after the first month.
This description comes directly from the study's public registry record.
Generate Recruitment · 888-469-0033 · solairiastudy@generatebiomedicines.com
Always discuss trial participation with your own doctor first.
| Research Site 13 | Bakersfield, California, United States | Recruiting |
| Research Site 12 | Inglewood, California, United States | Recruiting |
| Research Site 10 | West Covina, California, United States | Recruiting |
| Research Site 06 | Miami, Florida, United States | Recruiting |
| Research Site 03 | Miami, Florida, United States | Recruiting |
| Research 09 | Orlando, Florida, United States | Recruiting |
| Research Site 01 | Tamarac, Florida, United States | Recruiting |
| Research Site 04 | Tampa, Florida, United States | Recruiting |
| Research Site 05 | Tampa, Florida, United States | Recruiting |
| Research Site 20 | Fall River, Massachusetts, United States | Recruiting |
| Research Site 02 | Ypsilanti, Michigan, United States | Recruiting |
| Research Site 11 | Dayton, Ohio, United States | Recruiting |
+ 22 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07359846